文献速递核素与放射性配体治疗放射性药物与辐射防护

放射性标记DARPins肾摄取预防策略研究

On the prevention of kidney uptake of radiolabeled DARPins.
PubMed 文献 · EJNMMI Res · 2020-02-04

本研究探讨赖氨酸、明胶代血浆、马来酸钠、果糖、秋水仙碱、丙磺舒、甘露醇及呋塞米对[99mTc]Tc(CO)3-G3 DARPin肾摄取的影响。结果显示,马来酸钠使肾脏相关活性降低60.4±10.3%,果糖降低46.9±7.6%,而赖氨酸、明胶代血浆、秋水仙碱、丙磺舒、甘露醇及呋塞米均无效。

要点

  • 马来酸钠使[99mTc]Tc(CO)3-G3肾摄取降低60.4±10.3%,果糖降低46.9±7.6%。
  • 赖氨酸、明胶代血浆、秋水仙碱、丙磺舒、甘露醇及呋塞米对肾摄取无影响。
  • 马来酸钠对[99mTc]Tc(CO)3-9_29 DARPin同样有效,提示摄取机制不依赖DARPin结构。

核心结论

  • 常用临床策略(赖氨酸、明胶代血浆)未能有效降低[99mTc]Tc(CO)3-G3的肾摄取。
  • 果糖和马来酸钠降低近端小管细胞ATP水平,其减少肾重吸收提示存在ATP驱动的摄取机制。
  • 马来酸钠对G3和9_29两种DARPin均降低肾摄取,表明其摄取机制不依赖DARPin结构和结合位点组成。

研究设计与样本

  • 研究采用[99mTc]Tc(CO)3标记的G3 DARPin,比较联合注射或预先给予不同化合物对肾脏摄取的影响。
  • 评估的化合物包括赖氨酸、明胶代血浆、马来酸钠、果糖、秋水仙碱、丙磺舒、甘露醇和呋塞米。
  • 另对[99mTc]Tc(CO)3-9_29 DARPin测试了马来酸钠的效果,并通过肾脏放射自显影观察活性分布。

主要发现

  • 与对照相比,马来酸钠预处理使[99mTc]Tc(CO)3-G3肾脏相关活性降低60.4±10.3%。
  • 与对照相比,果糖预处理使[99mTc]Tc(CO)3-G3肾脏相关活性降低46.9±7.6%。
  • 赖氨酸或明胶代血浆联合注射未有效降低[99mTc]Tc(CO)3-G3的肾摄取。
  • 秋水仙碱、丙磺舒、甘露醇或呋塞米预处理对[99mTc]Tc(CO)3-G3肾摄取无影响。
  • 肾脏放射自显影显示所有研究组活性主要积聚于皮质。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Designed ankyrin repeat proteins (DARPins) are small engineered scaffold proteins (14-18 kDa) that demonstrated promising tumor-targeting properties in preclinical studies. However, high renal accumulation of activity for DARPins labeled with residualizing labels is a limitation for targeted radionuclide therapy. A better understanding of the mechanisms behind the kidney uptake of DARPins could aid the development of strategies to reduce it. In this study, we have investigated whether the renal uptake of [99mTc]Tc(CO)3-G3 DARPin could be reduced by administration of compounds that act on various parts of the reabsorption system in the kidney. RESULTS: Co-injection of lysine or Gelofusine was not effective for the reduction of kidney uptake of [99mTc]Tc(CO)3-G3. Administration of sodium maleate before the injection of [99mTc]Tc(CO)3-G3 reduced the kidney-associated activity by 60.4 ± 10.3%, while administration of fructose reduced it by 46.9 ± 7.6% compared with the control. The decrease in the kidney uptake provided by sodium maleate was also observed for [99mTc]Tc(CO)3-9_29 DARPin. Preinjection of colchicine, probenecid, mannitol, or furosemide had no effect on the kidney uptake of [99mTc]Tc(CO)3-G3. Kidney autoradiography showed mainly cortical accumulation of activity for all studied groups. CONCLUSION: Common clinical strategies were not effective for the reduction of kidney uptake of [99mTc]Tc(CO)3-G3. Both fructose and maleate lower the cellular ATP level in the proximal tubule cells and their reduction of the kidney reuptake indicates the involvement of an ATP-driven uptake mechanism. The decrease provided by maleate for both G3 and 9_29 DARPins indicates that their uptake proceeds through a mechanism independent of DARPin structure and binding site composition.

来源:EJNMMI Res,查看原文。版权归原作者所有。

引用

  1. Altai M, Garousi J, Rinne SS, et al. On the prevention of kidney uptake of radiolabeled DARPins. EJNMMI Res. 2020. PMID: 32020413. doi:10.1186/s13550-020-0599-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。